TRANSCRIPTIONAL REGULATION OF TH1/TH2 DIFFERENTIATION

TH1/TH2 分化的转录调控

基本信息

  • 批准号:
    6164011
  • 负责人:
  • 金额:
    $ 11.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-03-15 至 2002-02-28
  • 项目状态:
    已结题

项目摘要

Acquiring the ability to selectively produce interferon gamma (IFNgamma) or interleukin 4 (lL4) is a fundamental property of the immune system and enables T cell subsets (T helper 1, TH1, T helper 2, TH2) to deliver their effector functions. While the accumulated data clearly validate the polarization paradigm, the molecular mechanisms which control differentiation of naive T cells into memory TH1 or TH2 cells are not well understood. Much of what is known about regulation of gene transcription and the activity of individual response elements is derived from studies using immortalized cell lines. Very little is known about the regulation of transcriptional elements in primary cells nor about how transcriptional activity is regulated as primary cells differentiate or respond to external stimuli. This is largely due to the lack of an experimental system which permits investigation of promoter-directed transcriptional activity in primary cells. To address these questions, a novel experimental system will be employed. This system utilizes transgenic mice which express the luciferase gene under the control of a) proximal (prox. b-ZlP[IFNgamma]) and b) distal (dist. b-ZIP[IFNgamma]) response elements from the IFNgamma promoter, which bind b-ZIP transcription factors, c) the -538 to + 64 bp IFNgamma promoter, and d) a response element from the lL4 promoter which binds NF-AT/AP-1 transcription factors. The hypothesis to be tested is that acquisition of memory results from changes in transcriptional activity. The specific aims will focus on a) analyzing changes in transcriptional activity as naive T cells differentiate into effector T cells, b) determining how modulation of gene expression alters transcriptional activity, c) identifying transcription factors required for transcriptional activity, and d) determining if genetic regulation of cytokine production is reflected at the level of transcriptional activity. The long term goals of this project are to understand the molecular events which prevent naive T cells from producing IFNgamma and IL4 and which allow memory T cells to selectively produce these cytokines and to identify the genetic loci which control the development of TH1 or TH2 immunity. In a more general sense, these studies will examine changes in transcriptional activity as cells differentiate in a natural environment and acquire new properties. The immune-based pathology associated with many infectious diseases, including HIV infection, may result from overexpression of lL4 and the pathology associated with autoimmune diseases may result from overexpression of IFNgamma. Understanding regulation of cytokine gene expression may make it possible to correct overexpression of these genes and alleviate pathology associated with these diseases.
获得选择性产生干扰素γ(IFN γ)的能力 或白细胞介素4(IL 4)是免疫系统的基本特性, 使T细胞亚群(T辅助细胞1,TH 1,T辅助细胞2,TH 2)能够递送 其效应器功能。虽然积累的数据清楚地证实了 极化范式,控制的分子机制, 幼稚T细胞向记忆性TH 1或TH 2细胞的分化并不 很好理解。关于基因调控的大部分知识 转录和活性的个别反应元件是衍生 从永生化细胞系的研究中很少有人知道 原代细胞中转录元件的调节也不知道如何调节 转录活性随着原代细胞分化或 对外界刺激作出反应。这主要是由于缺乏一个 实验系统,允许研究启动子导向的 原代细胞中的转录活性。为了解决这些问题, 将采用新颖的实验系统。该系统利用 转基因小鼠,其在以下基因的控制下表达荧光素酶基因: a)近端(prox. b-ZIP [IFN γ])和B)远端(dist. b-ZIP[IFN γ]) 来自IFN γ启动子的反应元件,其结合b-ZIP c)-538至+64 bp IFN γ启动子,和d) 来自IL 4启动子的结合NF-AT/AP-1的应答元件 转录因子有待检验的假设是, 记忆力的变化来自于转录活性的变化。具体 aims将侧重于a)分析转录活性的变化, 幼稚T细胞分化成效应T细胞,B)确定如何 基因表达的调节改变转录活性,c) 鉴定转录活性所需的转录因子, 和d)确定细胞因子产生的遗传调节是否 反映在转录活性水平上。长期目标 这个项目的目的是了解阻止 幼稚T细胞产生IFN γ和IL 4,并允许记忆T细胞 细胞选择性地产生这些细胞因子, 控制TH 1或TH 2免疫发展的基因座。以更 一般意义上,这些研究将检查转录的变化, 细胞在自然环境中分化并获得新的 特性.与许多感染性疾病相关的免疫病理学 包括HIV感染在内的疾病可能是由IL 4的过表达引起的, 与自身免疫性疾病相关的病理学可能是由于 IFN γ的过度表达。了解细胞因子基因的调控 表达可以纠正这些基因的过度表达 并减轻与这些疾病相关的病理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas M. Aune其他文献

Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
OKT3 引起的人类 T 细胞激活可被 CD44 单克隆抗体抑制。
  • DOI:
    10.4049/jimmunol.147.8.2493
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    B. Rothman;M. Blue;Kevin Kelley;D. Wunderlich;D. Mierz;Thomas M. Aune
  • 通讯作者:
    Thomas M. Aune
Methotrexate and its mechanisms of action in inflammatory arthritis
甲氨蝶呤及其在炎性关节炎中的作用机制
  • DOI:
    10.1038/s41584-020-0373-9
  • 发表时间:
    2020-02-17
  • 期刊:
  • 影响因子:
    32.700
  • 作者:
    Bruce N. Cronstein;Thomas M. Aune
  • 通讯作者:
    Thomas M. Aune
Bromodomain inhibitor JQ1 reversibly blocks IFN-γ production
溴结构域抑制剂 JQ1 可逆性地阻断 IFN-γ 的产生
  • DOI:
    10.1038/s41598-019-46516-x
  • 发表时间:
    2019-07-16
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Hunter R. Gibbons;Deborah J. Mi;Virginia M. Farley;Tashawna Esmond;Mary B. Kaood;Thomas M. Aune
  • 通讯作者:
    Thomas M. Aune

Thomas M. Aune的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas M. Aune', 18)}}的其他基金

Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNA 作为流感疫苗佐剂
  • 批准号:
    10605272
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNA 作为流感疫苗佐剂
  • 批准号:
    10453106
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
A-to-I 编辑缺失会刺激 SARS-CoV-2 抗病毒反应
  • 批准号:
    10353022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
A-to-I 编辑缺失会刺激 SARS-CoV-2 抗病毒反应
  • 批准号:
    10615086
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
LncRNAs tether transcription factors to enable locus-specific regulation and sustain memory T cell phenotype
LncRNA 束缚转录因子以实现位点特异性调节并维持记忆 T 细胞表型
  • 批准号:
    9387202
  • 财政年份:
    2017
  • 资助金额:
    $ 11.61万
  • 项目类别:
Long non-coding RNA signatures to distinguish fibromyalgia syndrome from rheumatic diseases
长非编码 RNA 特征可区分纤维肌痛综合征和风湿性疾病
  • 批准号:
    9555179
  • 财政年份:
    2017
  • 资助金额:
    $ 11.61万
  • 项目类别:
Long non-coding RNA signatures to classify multiple sclerosis
用于对多发性硬化症进行分类的长非编码 RNA 特征
  • 批准号:
    9405679
  • 财政年份:
    2016
  • 资助金额:
    $ 11.61万
  • 项目类别:
Long non-coding RNA signatures to classify multiple sclerosis
用于对多发性硬化症进行分类的长非编码 RNA 特征
  • 批准号:
    9136402
  • 财政年份:
    2016
  • 资助金额:
    $ 11.61万
  • 项目类别:
Cell cycle checkpoint defects lead to chronic inflammation in RA
细胞周期检查点缺陷导致 RA 慢性炎症
  • 批准号:
    8683107
  • 财政年份:
    2013
  • 资助金额:
    $ 11.61万
  • 项目类别:
Cell cycle checkpoint defects lead to chronic inflammation in RA
细胞周期检查点缺陷导致 RA 慢性炎症
  • 批准号:
    8582351
  • 财政年份:
    2013
  • 资助金额:
    $ 11.61万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了